BioTexTers - Manuscript Development and Correction
The core team of BioTexTers is highly qualified with academic experience spanning over 40 years, specializing in original innovative research and script writing in biomedical sciences. Directors of the team have published over 300 full research publications in high impact journals of publishers like John Wiley, Oxford, Cambridge, Springer Nature, Taylor & Francis, Elsevier, Scopus, Web of Science and others. Several books and chapters have been written in collaboration even with Nobel Laureate Ferid Murad of US, Prof Ataur Rehman FRS and others.
We have successfully completed several national and international research projects, guided more than 50 PhD students, filed patents, organized several conferences and seminars in allied areas of clinical research. Members of BioTexTers also are also editors and reviewers of many international biomedical journals. They have the cutting-edge skills of manuscript development, based on vast experience, expertise and knowledge with innovative interpretations as their hall mark.
Historically we can trace the origins and development of scientific and technical publication to 1665 when the first “modern” scientific papers appeared and were characterized by non-standardised form and style. Subsequently, nearly 300 years ago, in an attempt to ensure that articles met a journal’s standards of quality and scientific validity, the peer-reviewed process for scientific manuscripts was born in England and France, which is still a stronghold of quality publication.
Since then, there has been an enormous proliferation of scientific journals and manuscripts so that, at present, the number of papers published annually is mind boggling. Published scientific papers are essential to disseminate relevant information and research findings, however with a huge production rate, quality gets affected, and few reach their objectives. Publication in good journals has always been a challenging task and several factors hamper this intricate process, right from the concept to publication.
Undoubtedly, lack of the necessary skills and experience in the process of writing and publishing is another possible barrier in the field of manuscript development. There is a dearth of specialists in this discipline who can represent a tool for intellectual enrichment and enhancement of standard publication. We aim to fill in this gap by having experienced academic professionals with cutting edge technologically innovative tools in manuscript development and corrections.
Our Mission
Our mission is to enable the translation of hard-earned scientific discoveries into impactful publications by providing high-quality manuscript development services to pharmaceutical companies. We are committed to scientific accuracy, clear and precise communication, and adherence to industry standards and guidelines.
Our Vision
Our vision is to be the preferred partner for pharmaceutical companies seeking to maximize the impact of their scientific discoveries through clear communication. We aim to be recognized for our scientific expertise, exceptional quality, and commitment to excellence, and to be the industry leader in scientific manuscript development services.
